Septodont

Septodont
IndustryDental, Medical Devices
Founded1932
FounderAnnie & Nestor Schiller
Headquarters
Saint-Maur-des-Fossés
,
France
Number of employees
2500
Websitewww.septodont.com

Septodont is a French pharmaceutical and medical device company mainly dedicated to developing, manufacturing and distributing dental consumables.[1] It is headquartered in Saint-Maur-des-Fossés (France)

History

Septodont was founded in France in 1932 by Annie & Nestor Schiller. In the 1950s and 1960s, under the leadership of Henri Schiller, Septodont started to introduce dental therapeutics and to focus on dental anesthesia with local anesthetics in single use cartridges. Beyond the focus on dental anesthesia, Septodont invested in Research and Development towards bioactive and biocompatible therapeutic solutions.

Between 2014 and 2016, Septodont made three acquisitions outside France. In 2014, the company acquired TDV, a restorative-products manufacturer based in Pomerode, Santa Catarina, Brazil.[2] In October 2015, its Canadian subsidiary Novocol Healthcare acquired a majority stake in Duoject Medical Systems, a Quebec-based designer of injection devices.[3] In February 2016, Septodont acquired DLA, an injectable dental-anesthetic manufacturing plant in Catanduva, São Paulo, Brazil, from Dentsply International.[2] The company also opened a new manufacturing unit for injectable anesthetics at its headquarters in Saint-Maur-des-Fossés in 2016.[4]

Beyond the dental field, through its subsidiary Novocol Healthcare, Septodont partners with pharmaceutical and medical device companies.[5]

Septodont remains a 100% family-owned business.[6] In June 2025, Olivier Schiller transitioned from Chief Executive Officer to Chairman of the Board, with Karim Khadr succeeding him as CEO.[7]

Products

Notes & references

  1. ^ "SEPTODONT | FRENCH HEALTHCARE ALLIANCE CHINA - Business France". french-healthcare-alliance.com.cn. Retrieved 2024-04-29.
  2. ^ a b "Septodont acquires injectable dental anesthetic manufacturing plant from Dentsply International". Dentistry IQ. February 2016. Retrieved 5 May 2026.
  3. ^ "Novocol Healthcare, a subsidiary of Septodont, acquires device company Duoject". Dentistry IQ. November 2015. Retrieved 5 May 2026.
  4. ^ "Investing in growth: Septodont builds new production facilities". Dental Tribune. 18 April 2017. Retrieved 5 May 2026.
  5. ^ "Novocol Healthcare, a subsidiary of Septodont, acquires device company Duoject". Dentistry IQ. 2015-11-03. Retrieved 2026-05-08.
  6. ^ "Septodont Announces New CEO". Dentaltown. 2025. Retrieved 2026-05-08.
  7. ^ "Septodont Selects Karim Khadr to Be Next CEO". Dentistry Today. 2025-05-07. Retrieved 2026-05-08.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.